. Author manuscript; available in PMC: 2015 Mar 5.

Published in final edited form as: J Nucl Med. 2014 Jul 14;55(9):1552–1556. doi: 10.2967/jnumed.114.140871

TABLE 1.

SLN Accumulation

Number of SLNs	Location of SLNs	Time (h)	Tilmanocept injected (nmol)	Percentage injected dose^*	IRDye800CW (nmol)	Extraction (%)^*	Fluorescence intensity (kcts s⁻¹ μW^minus;1)^†
8	Popliteal	1.0	1.7	0.95 ± 0.78	0.024 ± 0.020^‡	99.4 ± 4.0	6.22 ± 2.45^‡
8	Popliteal	36.0	1.7	0.56 ± 0.39^‡	0.014 ± 0.010^‡	98.5 ± 0.9	8.62 ± 3.72^‡
8	Popliteal	1.0	8.4	1.64 ± 0.77	0.21 ± 0.10	95.1 ± 5.2	19.1 ± 9.23
8	Popliteal	36.0	8.4	1.21 ± 0.33	0.15 ± 0.04	94.2 ± 5.9	11.6 ± 4.24

Measured by γ well counter (100–200 keV).

^†

Measured by Optix MX2.

^‡

P < 0.05 for comparison with data from same time but different amount of injected tilmanocept.

Data are mean ± SD.